LEXX
Lexaria Bioscience Corp. Common Stock
Latest price
As of Oct 29, 2026, 6:06 PM EDT · Market data by Massive
Market cap
$7.0M
Volume
39.3K
Previous close
$3.30
Day range
$3.30 – $3.87
Listed
Sep 8, 2006
Coverage
3 articles
Price performance
Recent trading
Newsroom
Latest LEXX coverage
Lexaria Bioscience Turns Focus to Dementia and Diabetes with New Studies
[ad_1] NEW YORK, NY – (NewMediaWire) – November 21, 2022 – PCG Digital — Lexaria Bioscience (Nasdaq: LEXX) is investigating the potential therapeutic utility of its proprietary DehydraTECHTM-CBD against dementia and diabetes, two of the world’s biggest public health crises. The global dementia drug market is projected to reach $32.3 b
Lexaria Hits Important Anti-Viral Milestone with In Vitro Test of DehydraTECH(TM)
[ad_1] New York, NY – (NewMediaWire) – June 17, 2021 – PCG Digital — Lexaria Bioscience Corp. (NASDAQ:LEXX) hit a major milestone this week with their patented DehydraTECHTM technology. An IC50 in vitro study was completed with COVID-19 SARS-CoV-2 antivirals Remdesivir and Ebastine and concluded that their formulation and processing m
Lexaria is Expanding CBD Use Beyond Medical Applications into $2.65 Billion Marketplace
[ad_1] New York, NY – (NewMediaWire) – April 08, 2021 – PCG Digital — The team at Lexaria Bioscience (Nasdaq:LEXX), a leader in cannabinoid research, has been thinking outside the box. Utilizing DehydraTECHTM, their proprietary drug delivery technology, they are showing that its benefits can enrich more than just CBD medical applicati